Skip to main content

CDKN2 Deletions in Leukemia-Derived Cell Lines: Detection by Fluorescence In Situ Hybridization with Interphase Cells

  • Conference paper
Acute Leukemias VI

Abstract

Hemizygous and homozygous deletions of chromosomal band 9p21 have been detected in various tumor types as well as in more than 20% of acute lymphoblastic leukemia. Recently, the CDKN2 gene (pl6INK4A, MTS I, CDK4I) has been proposed as a candidate tumor suppressor gene because it is frequently deleted in cell lines derived from multiple tumor types. We examined 18 leukemia-derived cell lines (13 T-ALL, 3 B-cell-precursor ALL,1 AML,1 CML-blast crisis) by polymerase chain reaction and Southern blot analysis to further define the frequency and size of 9p deletions in hematological malignancies. Homozygous CDKN2 deletions were detected in 16 cell lines (89%). Interphase fluorescence in situ hybridization (FISH) is a powerful method to detect chromosomal rearrangements, including submicroscopic deletions. Using a cosmid contig of the CDKN2 region, we performed interphase FISH in nine cell lines to study the accuracy of this method in detecting 9p deletions. Interphase FISH determined accurately all deletions of the tumor suppressor region previously detected by Southern blot or PCR. In six cell lines the cosmid contig was completely deleted. In one cell line, the intensity of the hybridization signals was significantly reduced, indicating a partial deletion of the hybridization region. One cell line had a hemizygous deletion which is difficult to detect by molecular techniques. Genomic deletions seem to be the predominant mechanism of CDKN2 inactivation in acute leukemias. Interphase FISH will play an important role in defining the frequency of CDKN2 deletions in primary tumors, because it is able reliably to analyze clinical samples that are contaminated by normal cells.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Chilcote, R.R., Brown, E., and Rowley, J.D. Lymphoblastic leukemia with lymphomatous features associated with abnormalities of the short arm of chromosome 9. N Engl J Med, 313: 286–291, 1985.

    Article  PubMed  CAS  Google Scholar 

  2. Murphy, S.B., Raimondi, S.C., Rivera, G.K., Crone, M., Dodge, R.K., Behm. F.G., Pui, C.H., and Williams, D.L. Nonrandom abnormalities of chromosome 9p in childhood acute lymphoblastic leukemia. Blood, 74: 409–415, 1989.

    PubMed  CAS  Google Scholar 

  3. Kamb, A., Gruis, N.A., Weaver, F.J., Liu, Q., Harshman, K., Tavtigian, S.V., Strockert, Day III, R., Johnson, B.E., and Skolnick, M.H. A cell cycle regulator potentially involved in genesis of many tumor types. Science, 264: 436–40, 1994.

    Article  PubMed  CAS  Google Scholar 

  4. Diaz, M.O., Ziemin, S., Le Beau, M.M., Pitha, P., Smith, S.D., Chilcote,.R.R., and Rowley, J.D. Homozygous deletion of the α- and β-interferon genes in human leukemia and derived cell lines. Proc Natl Acad Sci USA, 85: 5259–5263, 1988.

    Article  PubMed  CAS  Google Scholar 

  5. Diaz, M.O., Rubin, C.M., Harden, A., Ziemin, S., Larson, R.A., LeBeau, M.M., and Rowley, J.D. Deletions of interferon genes in acute lymphoblastic leukemia. N Engl J Med, 322: 77–82, 1990.

    Article  PubMed  CAS  Google Scholar 

  6. James, C.D., J., C., Caarlbom, E., Nordenskjold, M., Cavenee, W.K., and Collins, V.P. Chromosome 9 deletion mapping reveals interferon A and interferon B gene deletions in human glial tumors. Cancer Res, 51: 1684–1688, 1991.

    PubMed  CAS  Google Scholar 

  7. Olopade, O.I., Jenkins, R.B., Ransom, D.T., Malik, K., Pomykala, H., Nobori, T., Cowan, J.M., Rowley, J.D., and Diaz, M.O. Molecular analysis of deletions of the short arm of chromosome 9 in human gliomas. Cancer Res, 52: 2523–2529, 1992.

    PubMed  CAS  Google Scholar 

  8. Olopade, O.I., Buchhagen, D.L., Malik, K., Sherman, J., Nobori, T., Bader, S., Nau, M.M., Gazdar, A.F., Minna, J.D., and Diaz, M.O., Homozygous loss of the interferon genes defines the critical region on 9p that is deleted in lung cancers. Cancer Res, 53: 2410–2415, 1993.

    PubMed  CAS  Google Scholar 

  9. Serrano, M., Hannon, G.J., and Beach, D. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4. Nature, 366: 704–707, 1993.

    Article  PubMed  CAS  Google Scholar 

  10. Nobori, T., Miura, K., Wu, D.J., Lois, A., Takabayashi, K., and Carson, D.A. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature, 368: 753–756, 1994.

    Article  PubMed  CAS  Google Scholar 

  11. Hannon, G.J. and Beach, D. pl5INK4B is a potential effector of TGF-β-induced cell cycle arrest. Nature, 371: 257–261, 1994.

    Article  Google Scholar 

  12. James, C.D., Carlboom, E., Dumanski, J.D., Hansen, M., Nordenskjold, M., Collins, V.P., and Cavenee, W.K. Clonal genomic alterations in glioma malignancy stages. Cancer Res, 48: 5546–5551, 1988.

    PubMed  CAS  Google Scholar 

  13. Feinberg, A.P., and Vogelstein, B. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal Biochem, 132: 6–13, 1983.

    Article  PubMed  CAS  Google Scholar 

  14. Bohlander, S.K., Dreyling, M.H., Hagos, F., Sveen, L., Olopade, O.I., and Diaz, M.O. Mapping of a putative tumor suppressor gene on chromosome 9 band p21-22 with microdissection probes. Genomics, 24: 211–217, 1994.

    Article  PubMed  CAS  Google Scholar 

  15. Olopade, O.I., Pomykala, H.M., Hagos, F., Sveen, L.W., Espinosa III, R., Dreyling, M.H., Gursky, S., Stadler, W.M., Le Beau, M.M., and Bohlander, S.K. Construction of a 2.8 megabase YAC contig and cloning of the methyladenosine phosphorylase (MTAP) gene from the tumor suppressor region on 9p2. Proc Natl Acad Sci USA, in press.

    Google Scholar 

  16. Schneider, C., Owen, M.J., Banville, D., and Williams, J.G. Primary structure of the human transferrin receptor deduced from the mRNA sequence. Nature, 311: 675–678, 1984.

    Article  PubMed  CAS  Google Scholar 

  17. Henco, K., Brosius, J., Fujisawa, J.I., Haynes, J.R., Hochstadt, J., Kovacic, T., Pasek, M., Schambock, A., Schmid, S., Todokoro, K., Walchli, M., Nagata, S., and Weissmann, C. Structural relationship of human interferon alpha genes and pseudogenes. J Med Biol, 185: 227–260, 1988.

    Google Scholar 

  18. Le Beau, M.M. Cytogenetic analysis of hematological malignant diseases. In: M.J. Barch, The ACT cytogenetics laboratory manual, pp.395–445. New York: Raven Press, 1994.

    Google Scholar 

  19. Dreyling, M., Olopade, O.I., and Bohlander, S.K. A method for screening arrayed cosmid libraries with mega insert yeast artificial chromosomes. Nucl Acids Res, in press.

    Google Scholar 

  20. Erickson, P., Gao, J., Chang, K.S., Look, T., Whisenant, E., Raimondi, S., Lasher, R., Trujillo, J., Rowley, J.D., and Drabkin, H. Identification of breakpoints in t(8;21) acute myelogenous leukemia and isolation of a fusion transcript AML1/ETO, with similarity to drosophila segmentation gene, runt. Blood, 80: 1825–831, 1992.

    PubMed  CAS  Google Scholar 

  21. Moyzis, R.K., Albright, K.L., Bartholdi, M.F., Cram, L.S., Deaven, L.L., Hildebrand, C.E., Joste, N.E., Longmire, J.L., Meyne, J., and Schwarzacher-Robinson, T. Human chromosome-specific repetitive DNA sequences: Novel marker for genetic analysis Chromosoma, 95: 375–386, 1987.

    Article  PubMed  CAS  Google Scholar 

  22. Bohlander, S.K., Espinosa III, R., Fernald, A.A., Rowley, J.D., Le Beau, M.M., and Diaz, M.O. Sequence-independent amplification and labeling of yeast artificial chromosomes for fluorescence in situ hybridization. Cytogenet Cell Genet, 65: 108–110, 1994.

    Article  PubMed  CAS  Google Scholar 

  23. Rowley, J.D., Diaz, M.O., Espinosa III, R., Patel, Y.D., van Melle, E., Ziemin, S., Taillon-Miller, P., Lichter, P., Evans, G.A., Kersey, J.H., Ward, D.C. Domer, P.H., and Le Beau, M.M. Mapping chromosome band 11q23 im human acute leukemia with biotinylated probes: Identification of 11q23 translocation breakpoints with a yeast artificial chromosome. Proc Natl Acad Sci USA 87: 9358–9362, 1990.

    Article  PubMed  CAS  Google Scholar 

  24. Ogawa, S., Hirano, N., Sato, N., Takahashi, T., Hangaishi, A., Tanaka, K., Kurokawa, M., Tanaka, T., Mitani, K., Yazaki, Y., and Hirai, H. Homozygous loss of the cyclin-dependent kinase 4-inhibitor (pi6) gene in human leukemias. Blood, 84: 2431–2435, 1994.

    PubMed  CAS  Google Scholar 

  25. Nakamaki, T., Tobler, A., Schwaller, J., Tsuruoka, N., Miller, C.W., and Koeffler, H.P. pl6-alterations in myeloid leukemias. Blood, 84(Suppl 1): 48a, 1994 (abstract).

    Google Scholar 

  26. Gombart, A.F., Shintaku, I.P., Said, J.W., Miller, C.W., and Koeffler, H.P. Alterations of the CDK4/MTS1 (cyclin-dependent kinase 4 inhibitor/ multiple tumor suppressor 1) gene in uncultured B-cell lymphoma. Blood, 84 (Suppl 1): 445a, 1994(abstract).

    Google Scholar 

  27. Cairns, P., Mao, L., Merlo, A., Lee, D.J., Schwab, D., Ebry, Y., Tokino, K., van der Riet, P., Blaugrund, J.E., and Sidransky, D. Rates of pl6 (MTSl) mutations in primary tumors with 9p loss. Science, 265: 415–416, 1994(letter).

    Article  PubMed  CAS  Google Scholar 

  28. Giani, C. and Finocchiaro, G. Mutation rate of the CDKN2 gene in malignant gliomas. Cancer Res, 54: 6338–6339, 1994.

    PubMed  CAS  Google Scholar 

  29. Jen, J., Harper, J.W., Bigner, S.H., Bigner, D.D., Papadopoulos, N., Markowitz, S., Willson, J.K.V., Kinzler, K.W., and Vogelstein, B. Deletion of pl6 and p15 genes in brain tumors. Cancer Res, 54: 6353–6358, 1994.

    PubMed  CAS  Google Scholar 

  30. Okamoto, A., Demetrick, D.J., Spillare, E.A., Hagiwara, K., Hussain, S.P., Bennett, W.P., Forrester, K., Gerwin, B., Serrano, M., Beach, D.H., and Harris, C.C. Mutations and altered expression of pl6INK4 in human cancer. Proc Natl Acad Sci USA, 91: 11045–11049, 1994.

    Article  PubMed  CAS  Google Scholar 

  31. Quesnel, B., Preudhomme, C., Philippe, N., Vanrumbeke, M., Dervite, I., Lai, J.L., Bauters, F., Wattel, E., and Fenaux, P. pl6 gene homozygous deletions in acute lymphoblastic leukemia. Blood, 85: 657–663, 1995.

    PubMed  CAS  Google Scholar 

  32. Stilgenbauer, S., Dohner, H., Bulgay-Morschel, M., Weitz, S., Bentz, M., and Lichter, P. High frequency of monoallelic retinoblastoma gene deletion in B-cell chronic lymphoid leukemia shown by interphase cytogenetics. Blood, 81: 2118–2124, 1993.

    PubMed  CAS  Google Scholar 

  33. Bohlander, S.K., Espinosa III, R., Le Beau, M.M., Rowley, J.D., and Diaz, M.O. A method for the rapid sequence-independent amplification of microdissected chromosomal material. Genomics, 13: 1322–1324, 1992.

    Article  PubMed  CAS  Google Scholar 

  34. Nelson, D.L., Ledbetter, S.A., Corbo, L., Victoria, M.F., Ramirez-Solis, R., Webster, T.D., Ledbetter, D.H., and Caskey, C.T. Alu polymerase chain reaction: A method for rapid isolation of humanspecific sequences from complex DNA sources. Proc Natl Acad Sci USA, 86: 6686–6690, 1989.

    Article  PubMed  CAS  Google Scholar 

  35. Tocharentanaphol, C., Cremer, M., Schröck, E., Blonden, L., Kilian, K., Cremer, T., and Ried, T. Multicolor fluorescence in situ hybridization on metaphase chromosomes and interphase Halopreparations using cosmid and YAC clones for the simultaneous high resolution mapping of deletions in the dystrophin gene. Hum Genet, 93: 229–235, 1994.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1997 Springer-Verlag Berlin Heidelberg

About this paper

Cite this paper

Dreyling, M.H., Olopade, O.I., Bohlander, S.K. (1997). CDKN2 Deletions in Leukemia-Derived Cell Lines: Detection by Fluorescence In Situ Hybridization with Interphase Cells. In: Büchner, T., Schellong, G., Ritter, J., Creutzig, U., Hiddemann, W., Wörmann, B. (eds) Acute Leukemias VI. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 38. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-60377-8_16

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-60377-8_16

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-642-64379-8

  • Online ISBN: 978-3-642-60377-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics